FILTER
FILTERED INTERVIEW RESULTS
Ahmet Musul
CHAIRMAN, EKOL LOGISTICS
Ekol provides international freight, warehousing, distribution, foreign trade, customs, and supply-chain management services across Europe.
Serkan Barış
COUNTRY PRESIDENT, ASTRAZENECA
AstraZeneca Turkey provides an overview of its Turkish operations and opinions on the market.
Prof. Dr. Tanıl Kocagöz
HEAD OF DEPARTMENTS OF MEDICAL MICROBIOLOGY AND BIOTECHNOLOGY, ACIBADEM UNIVERSITY RESEARCH LABORATORY
Acibadem University is a private university founded in 2007, belonging to the Acibadem Healthcare Group. Professor Dr Kocagöz is a microbiology and infectious disease specialist.
Șirin Deha
FOUNDER & GM ERA PHARMA SOLUTIONS
ERA Pharma Solutions is a contract research organization (CRO) established in 2010 to provide drug discovery, development and lifecycle management services for the pharmaceutical industry.
Hasan Ulusoy
CHAIRMAN, NOBEL İLAÇ
Nobel is an internationally active pharmaceutical company founded in 1964, representing the Turkish brand in a wide range of geographies.
Pelin İșçener
MARKETING AND SALES DIRECTOR, ECZACIBAȘI MONROL NÜKLEER ÜRÜNLER
Eczacıbaşı Monrol specializes in producing agents for PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scans, which are critical for detecting cancer, cardiological diseases and brain disorders, among other serious diseases.
Cem Erdem
CO-FOUNDER AND CEO, FLORABIO TEKNOLOJI
Florabio is a life science company with proprietary technology, know-how and experience in research and development of therapeutic proteins.
Muzaffer Bal
GENERAL MANAGER, ALI RAIF
Ali Raif is one of the oldest Turkish Pharmaceutical companies, and has developed from manufacturing and marketing under license to producing generics and other drugs.
Dr. Seyfullah Dağıstanlı & Aytek Dağıstanlı
FOUNDER & BUSINESS DEVELOPMENT MANAGER, DELTAPV
DeltaPV is Turkey’s leading provider of pharmacovigilance in Turkey and exports its services abroad.
Ferhat Farsi
CEO AND CO-FOUNDER, CINNAGEN
CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
